S. Oro

Satb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation

Approach to the Patient With Presumed Cellulitis

Psoriasis

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

Psoriasis

Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)

Psoriasis

Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action

European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Extracorporeal photopheresis for the treatment of autoimmune diseases

Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy

Mycosis fungoides and the Sézary syndrome

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile

Immunological and Toxicological Considerations for the Design of Liposomes

CutaneousT‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management

Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?

How I treat mycosis fungoides and Sézary syndrome

Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma

Follow-up of the T-cell clonality in Sezary patients treated by extracorporeal photopheresis using a new assay: the immunoscope technique

Survenue d’un psoriasis au cours d’un traitement par infliximab pour fasciite de Shulman

Gemcitabine treatment in cutaneous T-cell lymphoma: a multicentre study of 23 cases

Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients

Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases

French referral center management of Stevens–Johnson syndrome/toxic epidermal necrolysis

A prospective study on the evolution of the T-cell repertoire in patients with Sezary syndrome treated by extracorporeal photopheresis

First-line Treatment of Pemphigus Vulgaris With a Combination of Rituximab and High-Potency Topical Corticosteroids

[Painful bruising syndrome mimicking cellulitis of the leg].

Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases